| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 15, 2006
From the Divisions of Neuroradiology (R.W., R.I.A., A.J.F., S.P.S.) and Neurology (D.J.S., D.J.G.) and the North and East GTA Regional Stroke Centre, Sunnybrook Health Sciences Centre, and the Department of Public Health Sciences (G.T.), University of Toronto, Toronto, Canada. * To whom correspondence should be addressed. E-mail: richardaviv{at}lineone.net.
Background and Purpose--Morbidity and mortality in spontaneous intracerebral hemorrhage (ICH) are correlated with hematoma progression. We hypothesized that the presence of tiny, enhancing foci ("spot sign") within acute hematomas is associated with hematoma expansion. Methods--We prospectively studied 39 consecutive patients with spontaneous ICH by computed tomography angiography within 3 hours of symptom onset. Scans were reviewed by 3 readers. Patients were dichotomized according to the presence or absence of the spot sign. Clinical and radiological outcomes were compared between groups. The predictive value of this sign was assessed in a multivariate analysis. Results--Thirteen patients (33%) demonstrated 31 enhancing foci. Baseline clinical variables were similar in both groups. Hematoma expansion occurred in 11 patients (28%) on follow-up. Seventy-seven percent of patients with and 4% without hematoma expansion demonstrated the spot sign (P<0.0001). Sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratio for expansion were 91%, 89%, 77%, 96%, and 8.5, respectively. Interobserver agreement was high ( Conclusions--The computed tomography angiography spot sign is associated with the presence and extent of hematoma progression. Fewer patients achieve a good clinical outcome and hospital stay was longer. Further studies are warranted to validate the ability of this sign to predict clinical outcomes.
Revised on October 19, 2006
Accepted on October 29, 2006
CT Angiography "Spot Sign" Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage
Ryan Wada MD;
=0.92 to 0.94). In patients with the spot sign, mean volume change was greater (P=0.008), extravasation more common (P=0.0005), and median hospital stay longer (P=0.04), and fewer patients achieved a good outcome (modified Rankin Scale score <2), although the latter was not significant (P=0.16). No differences in hydrocephalus (P=1.00), surgical intervention (P=1.00), or death (P=0.60) were noted between groups. In multiple regression, the spot sign independently predicted hematoma expansion (P=0.0003).
This article has been cited by other articles:
![]() |
S. A. Mayer, N. C. Brun, K. Begtrup, J. Broderick, S. Davis, M. N. Diringer, B. E. Skolnick, T. Steiner, and the FAST Trial Investigators Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage N. Engl. J. Med., May 15, 2008; 358(20): 2127 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gazzola, R. I. Aviv, D. J. Gladstone, G. Mallia, V. Li, A. J. Fox, and S. P. Symons Vascular and Nonvascular Mimics of the CT Angiography "Spot Sign" in Patients With Secondary Intracerebral Hemorrhage Stroke, April 1, 2008; 39(4): 1177 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mayer and S. Schwab Advances in Critical Care and Emergency Medicine 2007 Stroke, February 1, 2008; 39(2): 261 - 263. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |